Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Sucampo Pharma Inc (SCMP)

Sucampo Pharma Inc (SCMP)
18.05 +0.05 (+0.28%) 02/13/18 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Tue, Feb 13th, 2018
Day Low
18.05
Day High
18.05
Open 18.05
Previous Close 18.00 18.00
Volume 303,068 303,068
Avg Vol 1,984,123 1,984,123
Stochastic %K 78.09% 78.09%
Weighted Alpha +64.00 +64.00
5-Day Change +0.10 (+0.56%) +0.10 (+0.56%)
52-Week Range 9.30 - 18.75 9.30 - 18.75
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 849,060
  • Shares Outstanding, K 47,170
  • Annual Sales, $ 230,060 K
  • Annual Income, $ 18,490 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.38
  • Price/Sales 3.39
  • Price/Cash Flow 7.47
  • Price/Book 21.18
  • Price/Earnings ttm 12.33
  • Earnings Per Share ttm 1.46
  • Most Recent Earnings $0.27 on 11/01/17
  • Next Earnings Date 03/14/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/17
See More
  • Average Estimate 0.34
  • Number of Estimates 3
  • High Estimate 0.36
  • Low Estimate 0.32
  • Prior Year 0.68
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.85 +1.12%
on 01/24/18
Period Open: 18.05
18.30 -1.37%
on 01/17/18
unch (unch)
since 01/12/18
3-Month
10.10 +78.71%
on 11/16/17
Period Open: 10.30
18.75 -3.73%
on 01/08/18
+7.75 (+75.24%)
since 11/13/17
52-Week
9.30 +94.09%
on 04/18/17
Period Open: 11.50
18.75 -3.73%
on 01/08/18
+6.55 (+56.96%)
since 02/13/17

Business Summary

Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of specialized medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products - AMITIZA, its lead product, and RESCULA - and a late-stage pipeline of product candidates in clinical...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 18.14
1st Resistance Point 18.07
Last Price 18.05
1st Support Level 17.94
2nd Support Level 17.88
3rd Support Level N/A

See More

52-Week High 18.75
Last Price 18.05
Fibonacci 61.8% 15.14
Fibonacci 50% 14.02
Fibonacci 38.2% 12.91
52-Week Low 9.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades